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A set of inhibitors that are useful for distinction of three types of human cytosolic glutathione transferase 
is presented. The near-neutral transferase is inhibited most effectively by Cibacron blue (I,, = 0.05 PM), 
the acidic transferase by Cibacron blue (I,, = 0.5 PM), and the basic transferase by tributyltin acetate (I,, 
= 0. IpM). The use of any of these two compounds makes possible differentiation between all three types 
of human transferase. 
Human glutathione transferase Discriminatory inhibitor 
1. INTRODUCTION 
Glutathione transferase (EC 2.5.1.18) occurs in 
multiple forms in most biological sources in- 
vestigated [I]. Like the family of cytochrome 
P-450 [2], the glutathione transferases are con- 
sidered to be involved in detoxication of 
xenobiotics as well as of compounds endogenous 
to the organism. A possible explanation for the ex- 
istence of isoenzymes of detoxication enzymes is 
that an ensemble of proteins with somewhat dif- 
ferent substrate specificities can metabolize a 
broader spectrum of toxic compounds than could 
a single enzyme. 
Several isoenzymes of glutathione transferase 
have been isolated from the cytosol fraction of 
human tissues, and three classes of the enzyme 
have been distinguished [1,3]. These classes have 
been referred to as basic (or a-f), near-neutral (or 
p), and acidic (or r/e) [4]. The members of the 
three classes have clearly different substrate 
specificities, indicating distinct roles of the various 
enzymes in detoxication reactions. In view of the 
non-uniform tissue distribution of the isoenzymes, 
and their different catalytic capacities, it is impor- 
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Isoenzyme Cibacron blue Organotin compound 
tant to be able to distinguish the types of 
transferase in previously uncharacterized samples. 
Investigations of the multiple forms of glutathione 
transferase in the rat have shown that a battery of 
tests are necessary for an accurate identification of 
the isoenzymes [4]. One such test involves the 
determination of the sensitivity to a set of in- 
hibitors [5]. The present communication provides 
such data for the three types of human glutathione 
transferase. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
S-Hexylglutathione and S-p-bromobenzylglu- 
tathione were synthesized by method A of Vince et 
al. [6] as detailed earlier [7]. All other chemicals 
were standard commercial products used without 
further purification. 
Stock solutions of S-hexylglutathione, S-p- 
bromobenzylglutathione, and the dye Cibacron 
blue F3GA (Color Index 61211) were made by 
dissolving the inhibitor in the minimal amount of 
0.1 M NaOH, followed by neutralization with 
0.1 M HCl and dilution with deionized water to 
the desired concentration. Hematin was similarly 
dissolved in 0.1 M NHj. Triphenyltin chloride was 
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dissolved in acetone, but dilutions were made with 
ethanol to avoid the comparatively higher in- 
hibitory action of acetone. Stock solutions as well 
as dilutions of all other inhibitors were made in 
95% (v/v) ethanol. 
2.2. Enzymes 
The three types of human glutathione 
transferase were obtained by published pro- 
cedures: acidic transferase (n) from placenta [7]; 
near-neutral (J) and basic transferases (cu-6) from 
adult liver [8]. Each of the three enzyme prepara- 
tions was homogeneous on dodecylsulfate-poly- 
acrylamide gel electrophoresis, but it is known that 
the basic fraction may contain up to at least 5 com- 
ponents with similar enzymatic properties [9, lo]. 
In view of the reported similarities, no attempt at 
separating basic components was made. 
2.3. Assay of enzyme activity 
Glutathione transferase activity was measured at 
30°C using 1 mM GSH and 1 mM l-chloro-2,4- 
dinitrobenzene as substrates. The latter substrate 
was added from a 20 mM stock solution in 95% 
ethanol to the reaction system (final volume 1 ml) 
containing 0.1 M sodium phosphate (pH 6.5). The 
reaction was started by the addition of the enzyme 
and was monitored spectrophotometrically at 
340 nm [ll]. The effect of inhibitors on the 
catalytic activity was studied by comparing the 
reaction rate in the presence and the absence of in- 
hibitor. The concentration of inhibitor giving 50% 
inhibition, the ZSO value, was determined by inter- 
polation from plots of remaining activity vs in- 
hibitor concentration. Inhibitor solutions were 
diluted appropriately before addition to the reac- 
tion system in order to maintain a constant concen- 
tration of organic solvent (if used) when the in- 
hibitor concentration was varied. 
3. RESULTS 
Table 1 gives a set of ZSO values for each of the 
three types of human glutathione transferase 
assayed with a variety of inhibitors. Most com- 
pounds listed inhibit at least one enzyme form 
significantly at 1 ,xM. The exceptions are 
triethyltin bromide and indomethacin, which were 
included because they are strong inhibitors of rat 
glutathione transferases 3-3 [5] and 4-4 (called 
VII by the authors, [12]), respectively. The data 
also show that virtually all inhibitors distinguish at 
least one isoenzyme from the other two. With 
Table 1 
Inhibition parameters, Iso values ~JM)~, for the three types of human GSH transferase 
Inhibitor Isoenzyme 
Basic Near-neutral Acidic 
(Q-t) Oc) (d 
Cibacron blue 5 0.05 0.5 
Gossypol acetic acid 50 2 >lOO 
Tributyltin acetate 0.1 0.5 4 
Triethyltin bromide 10 5 6 
Triphenyltin chloride 0.25 0.5 > 10 
Bromosulfophthalein 75 2 100 
Hematin 0.5 1 5 
S-Hexylglutathione 3 10 20 
S-(p-Bromobenzyl)glutathione 4 1 4 
Indomethacin 100 40 100 
Rose Bengal ’ 1 1 15 
a The 150 value is the concentration of inhibitor giving 50% inhibition of the enzyme 
activity assayed at pH 6.5, 30°C with 1 mM 1-chloro-2,4-dinitrobenzene and 1 mM 
GSH as substrates 
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some inhibitors, all three enzyme forms have 
discrete Iso values. Fig.1 shows the differential ef- 
fects of tributyltin acetate and Cibacron blue on 
the three types of transferase. Tributyltin acetate 
was the most potent inhibitor of the basic 
transferase and Cibacron blue the most effective 
with the near-neutral and the acidic types. 
However, in no case was a compound found to in- 
hibit the acidic transferase more strongly than both 
of the other enzyme forms. 
4. DISCUSSION 
The primary object of this investigation was to 
find a suitable set of inhibitors to be used for iden- 
tification of the three different types of cytosolic 
human glutathione transferase. For example, in- 
hibitors have been used (unpublished) to verify the 
conclusion that the acidic transferase in human 
fetal liver [13], is of the same type as the placental 
enzyme rather than of the category including the 
OJ 1 
[I Cibacron Blue OJM) 1 
C Tributyltin acetate] ()rM) 
Fig.1. Inhibition of the three types of human glutathione transferase as a function of the concentration of Cibacron 
blue (A) and tributyltin acetate (B). Remaining transferase activity of the basic (w) (o), the near-neutral &) (0) and 
the acidic (T) (A) enzyme forms was measured at pH 6.5 with I-chloro-2,4_dinitrobenzene as electrophilic substrate. 
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Clbacron Blue F3GA 
Fig.2. Structure of Cibacron blue F3GA. 
acidic forms detected in adult human liver [ 141. 
This example shows that the criterion of isoelectric 
point is not adequate for identification, since both 
the fetal and the adult enzyme forms considered 
are acidic proteins. Table 1 gives data that could be 
used for discrimination between the human isoen- 
zymes so far characterized. 
The information in table 1 could also be used in 
the design of metabolic studies with isolated cells. 
By judicious choice of inhibitors, one type of 
glutathione transferase may be selectively in- 
hibited, allowing evaluation of its contribution to 
metabolism and to protection of the cell. 
More detailed studies are required for 
characterizing the interaction of the inhibitors with 
the different enzyme forms. Nevertheless, the data 
in table 1 lead to the conclusion that both 
hydrophobic interactions and steric effects have 
decisive roles in determining the inhibitory 
strength of a given compound. For example, the 
related organotin compounds on the one hand, 
and the glutathione derivatives on the other hand, 
exhibit such differential inhibitory effects that sup- 
port this conclusion. Cibacron blue (fig.2) is one of 
the most potent glutathione transferase inhibitors, 
but the possible interpretation that binding of this 
compound signifies the presence of a dinucleotide 
fold in the protein [lS] is contradicted by the lack 
of inhibition of the transferases by NADf or 
NADP+. However, further investigations of in- 
hibitor binding may give information about the 
molecular topography of the different isoenzymes 
of glutathione transferase. 
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